BPIFA1 and lung carcinoma: Zheng et al. (2015) introduced shRNA against LunX into lung cancer tissue in vivo, which successfully disrupted local invasion, micrometastasis formation and metastatic colonization of lung cancer cells, thus inhibiting the initial and final steps of the invasion-metastasis cascade.